Morgan Lewis

Related Publications

03/06/14 FDA Updates Reprint Guidance, Reiterates Narrowness of Off-Label Safe-Harbor
FDA updates its recommendations for distribution of reprints, making requirements more specific and addressing additional types of materials typically distributed.
02/27/14 FTC Cracks Down on False Advertising in Dietary Supplements
Supplements making claims regarding diabetes, genetically customized nutritional benefits, and weight loss are slammed for false advertising.
View all publications

Related News

11/19/13 Pharmacists, Attorneys Question Whether Drug Compounding Bill Would Improve Safety, BNA's Daily Report for Executives
Although the drug industry generally supports the bill passed by the Senate Nov. 18, attorneys and some pharmacists question whether the bill really would improve the safety of compounded drugs.
09/06/11 Former FDA Regulatory Counsel Returns to Morgan Lewis
Morgan Lewis announces that Alexis Reisin Miller has returned to the firm as a partner in its FDA & Healthcare Practice, resident in Washington, D.C.
View all news
Photo of  Alexis Reisin Miller

Bar Admissions

  • District of Columbia
  • Maryland
View Printable List

Alexis Reisin Miller

Washington, D.C.
1111 Pennsylvania Ave., NW
Washington, DC 20004-2541
Phone: 202.739.5390
Fax: 202.739.3001

6 Publications Found
Date Title Publication
03/06/1403/06/14 FDA Updates Reprint Guidance, Reiterates Narrowness of Off-Label Safe-Harbor

pdf View LawFlash
Life Sciences and Healthcare LawFlash
02/27/1402/27/14 FTC Cracks Down on False Advertising in Dietary Supplements

pdf View LawFlash
Food Industry LawFlash
01/16/13January/February 2013 Evolving Roles of Physicians in Drug and Device Promotion, Journal of Health Care Compliance

pdf View Article
Article
07/25/1207/25/12 FDA User Fee Act Full of Surprises for Pharma and Biotech

pdf View LawFlash
Life Sciences and Healthcare LawFlash
02/09/1202/09/12 FDA Issues Three Draft Guidances for Biosimilars

pdf View LawFlash
Life Sciences and Healthcare LawFlash
01/11/1201/11/12 FDA Gets (Un)Social

pdf View LawFlash
Life Sciences and Healthcare LawFlash